LINC00114 and nasopharyngeal carcinoma: It competitively sponges miR-203 to regulate the ERK/JNK pathway to promote the progression and radioresistance of NPC.[22] Our study predicts that LINC00114 is upregulated in colon cancer tissues, which is consistent with Lv's study.